Investing Profile

Iris Wang

InvestorVC
Partner at Orbimed
orbimed.comHong Kong
Photo of Iris Wang, Partner at OrbiMed
cb
OrbiMed Partner
$1M - $75.0M
$4.0M
6
$18B
CompanyStageDateRound SizeTotal Raised
Dingdang Kuaiyao
Private EquityJun 2021$220M
$220M
EDDA Technology
Private EquityApr 2021$150M
$150M
LakeShore Biopharma
Series BFeb 2021$130M
$130M
Harbour Biomed
Series CJul 2020$100M
$100M
Akeso Biopharma
Series DNov 2019$150M
$150M
Alphamab Oncology
Series ANov 2018$100M
$160M
Co-investors: Adrian Cheng (CVentures)